(Q47304572)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Freudenreich O

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Henderson DC

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Fan X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Copeland PM

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Daley TB

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Nguyen DD

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Zhang H

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Hayden D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Cather C

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Evins AE

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Goff DC

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

English

0 references

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

Acta Psychiatrica Scandinavica

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

101-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17244173%20AND%20SRC:MED&resulttype=core&format=json

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

Schizophrenia and weight management: a systematic review of interventions to control weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

Present and future pharmacological approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X

Radioreceptor binding profile of the atypical antipsychotic olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00855.X